- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging drugs for the treatment of diabetic retinopathy
Authors
Keywords
-
Journal
EXPERT OPINION ON EMERGING DRUGS
Volume -, Issue -, Pages 1-11
Publisher
Informa UK Limited
Online
2020-07-25
DOI
10.1080/14728214.2020.1801631
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles
- (2020) Hiroki Tsujinaka et al. Nature Communications
- Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Patients With Neovascular Age-Related Macular Degeneration: Studies in Japan and the United States
- (2019) Derek Kunimoto et al. Ophthalmic Surgery Lasers & Imaging Retina
- Association of Intravitreal Anti–Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular Degeneration
- (2019) Lauren A. Dalvin et al. JAMA Ophthalmology
- Perturbed Biochemical Pathways and Associated Oxidative Stress Lead to Vascular Dysfunctions in Diabetic Retinopathy
- (2019) Nidhi Mahajan et al. Oxidative Medicine and Cellular Longevity
- Simultaneous Inhibition of Angiopoietin-2 and VEGF-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial
- (2019) Jayashree Sahni et al. OPHTHALMOLOGY
- Anti-VEGF Therapy for Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions
- (2019) Thomas J. Wubben et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
- (2019) Pravin U. Dugel et al. OPHTHALMOLOGY
- Classification of Strokes in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor
- (2019) Matthew R. Starr et al. Ophthalmic Surgery Lasers & Imaging Retina
- The estimated healthcare cost of diabetic retinopathy in Indonesia and its projection for 2025
- (2019) Muhammad Bayu Sasongko et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Intravitreal Ziv-Aflibercept: A Comprehensive Review
- (2019) Daniel Barmas-Alamdari et al. Seminars in Ophthalmology
- Risk of Death Associated With Intravitreal Anti–Vascular Endothelial Growth Factor Therapy
- (2019) Michele Reibaldi et al. JAMA Ophthalmology
- Intravitreal anti-VEGF agents and cardiovascular risk
- (2019) Massimo Porta et al. Internal and Emergency Medicine
- Two-year outcomes of intravitreal ziv-aflibercept
- (2018) Ahmad M Mansour et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Clinical pharmacology of intravitreal anti-VEGF drugs
- (2018) Stefano Fogli et al. EYE
- Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema
- (2018) Raj K. Maturi et al. JAMA Ophthalmology
- Overview of Systematic Reviews and Meta-analyses on Systemic Adverse Events Associated With Intravitreal Anti–Vascular Endothelial Growth Factor Medication Use
- (2018) Marie Thulliez et al. JAMA Ophthalmology
- Intravitreal Ziv-Aflibercept for Diabetic Macular Edema: 48-Week Outcomes
- (2018) Gabriel Costa de Andrade et al. Ophthalmic Surgery Lasers & Imaging Retina
- Gene therapy for visual loss: Opportunities and concerns
- (2018) Jia Hui Lee et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration
- (2018) David Callanan et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Risk of Systemic Adverse Events Associated with Intravitreal Anti–VEGF Therapy for Diabetic Macular Edema in Routine Clinical Practice
- (2018) Maya H. Maloney et al. OPHTHALMOLOGY
- Long-term Effects of Intravitreal 0.19 mg Fluocinolone Acetonide Implant on Progression and Regression of Diabetic Retinopathy
- (2017) Charles C. Wykoff et al. OPHTHALMOLOGY
- SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB
- (2017) Robert L. Avery et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Tyrosine kinase blocking collagen IV–derived peptide suppresses ocular neovascularization and vascular leakage
- (2017) Raquel Lima e Silva et al. Science Translational Medicine
- Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema
- (2016) Peter A. Campochiaro et al. Current Diabetes Reports
- Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases
- (2016) Jörg T Regula et al. EMBO Molecular Medicine
- Designed Ankyrin Repeat Proteins (DARPins): Binding Proteins for Research, Diagnostics, and Therapy
- (2015) Andreas Plückthun Annual Review of Pharmacology and Toxicology
- Ziv-aflibercept in macular disease
- (2015) Ahmad M Mansour et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema
- (2015) Takeshi Kita et al. DIABETES
- RANDOMIZED CONTROLLED STUDY OF INTRAVITREAL BEVACIZUMAB 0.16 MG INJECTED ONE DAY BEFORE SURGERY FOR PROLIFERATIVE DIABETIC RETINOPATHY
- (2015) Ayumu Manabe et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study
- (2015) Albert J. Augustin et al. BMC Ophthalmology
- Angiopoietin 2 Induces Pericyte Apoptosis via 3 1 Integrin Signaling in Diabetic Retinopathy
- (2014) S. W. Park et al. DIABETES
- Safety and Efficacy of Conbercept in Neovascular Age-Related Macular Degeneration
- (2014) Xiaoxin Li et al. OPHTHALMOLOGY
- Diabetic macular edema: new concepts in patho-physiology and treatment
- (2014) Xinyuan Zhang et al. Cell and Bioscience
- Ziv-aflibercept: A novel angiogenesis inhibitor for the treatment of metastatic colorectal cancer
- (2013) C. Chung et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Plasma kallikrein-kinin system and diabetic retinopathy
- (2013) Jia Liu et al. BIOLOGICAL CHEMISTRY
- Global Prevalence and Major Risk Factors of Diabetic Retinopathy
- (2012) J. W. Y. Yau et al. DIABETES CARE
- Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema
- (2012) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Inhibition of ongoing allergic reactions using a novel anti-IgE DARPin-Fc fusion protein
- (2011) A. Eggel et al. ALLERGY
- Pharmacokinetics of a long-lasting anti-VEGF fusion protein in rabbit
- (2011) Hong Li et al. EXPERIMENTAL EYE RESEARCH
- Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
- (2011) Michael J. Elman et al. OPHTHALMOLOGY
- The RESTORE Study
- (2011) Paul Mitchell et al. OPHTHALMOLOGY
- A Treat and Extend Regimen Using Ranibizumab for Neovascular Age-Related Macular DegenerationClinical and Economic Impact
- (2010) Omesh P. Gupta et al. OPHTHALMOLOGY
- Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
- (2010) Michael J. Elman et al. OPHTHALMOLOGY
- COMPARISON OF LASER PHOTOCOAGULATION FOR DIABETIC RETINOPATHY USING 532-NM STANDARD LASER VERSUS MULTISPOT PATTERN SCAN LASER
- (2010) MANISH NAGPAL et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Intravitreal Triamcinolone Acetonide Injection for Treatment of Refractory Diabetic Macular Edema
- (2009) Taygan Yilmaz et al. OPHTHALMOLOGY
- Glucocorticoids induce transactivation of tight junction genes occludin and claudin-5 in retinal endothelial cells via a novel cis-element
- (2008) Edward A. Felinski et al. EXPERIMENTAL EYE RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation